BamSEC and AlphaSense Join Forces
Learn More

Palisade Bio Inc.

NASDAQ: PALI    
Share price (12/20/24): $1.75    
Market cap (12/20/24): $2.327 million
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.1
from 8-K ~5 pages Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Palisade Bio, Inc
12/34/56
EX-3.1
from 8-K 23 pages Amended and Restated Bylaws of Palisade Bio, Inc
12/34/56
EX-3.01I
from 8-K 2 pages Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Palisade Bio, Inc
12/34/56
EX-3.1
from 8-K 19 pages Palisade Bio, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series B Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.1
from 8-K 24 pages Amended and Restated Bylaws of Palisade Bio, Inc. (Amended and Restated on August 10, 2022) 1
12/34/56
EX-3.3
from S-1/A 23 pages Corporate Offices
12/34/56
EX-3.4
from S-1/A 18 pages Palisade Bio, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series B Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.1
from 8-K 5 pages Amended and Restated Certificate of Incorporation of Seneca Biopharma, Inc. a Delaware Corporation
12/34/56
EX-3.01(IV)
from S-4 7 pages Exhibit 3.01(iv)
12/34/56
EX-3.01
from 8-K 1 page Certificate of Amendment of Certificate of Incorporation
12/34/56
EX-3.01(I)
from 8-K 3 pages Amended and Restated Certificate of Incorporation of Neuralstem, Inc. a Delaware Corporation
12/34/56
EX-3.01(I)
from 8-K 3 pages Articles of Incorporation or Bylaws
12/34/56
EX-3.01
from 8-K 11 pages Neuralstem, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series a 4.5% Convertible Preferred Stock Pursuant to Section 151(g) of the Delaware General Corporation Law
12/34/56
EX-3.01
from 8-K 11 pages Neuralstem, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series a 4.5% Convertible Preferred Stock Pursuant to Section 151(g) of the Delaware General Corporation Law
12/34/56
EX-3.01
from 8-K 31 pages Corporate Offices
12/34/56
EX-3.01
from 10-Q 3 pages Amended and Restated Certificate of Incorporation of Neuralstem, Inc. a Delaware Corporation
12/34/56
EX-3.01(I)
from 10-K 4 pages Articles of Incorporation or Bylaws
12/34/56
EX-3.2(I)
from 10QSB 25 pages Amended and Restated Bylaws of Neuralstem Inc. (Amended and Restated on July 16, 2007) 1 Bylaws of Neuralstem, Inc
12/34/56
EX-3.2
from SB-2/A 1 page Articles of Incorporation or Bylaws
12/34/56
EX-3.1
from SB-2/A 5 pages Certificate of Amendment to Certificate of Incorporation of Neuralstem
12/34/56